Topical SM04554 solution

DRUG2 trials

Sponsors

Biosplice Therapeutics, Inc.

Conditions

Androgenetic Alopecia

Phase 2

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

CompletedNCT02503137

Biosplice Therapeutics, Inc.Androgenetic Alopecia

Start: 2015-08-31End: 2016-04-30Updated: 2020-02-17

A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

CompletedNCT03742518

Biosplice Therapeutics, Inc.Androgenetic Alopecia

Start: 2018-11-01End: 2020-12-31Updated: 2021-12-28